|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 444.92 USD | -0.03% |
|
-0.43% | -1.86% |
| Market Cap | 113B 97.53B 89.88B 84.13B 158B 10,734B 160B 1,061B 414B 5,224B 424B 415B 18,089B | P/E Ratio 2026 * |
25.4x | P/E Ratio 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 100B 86.49B 79.7B 74.6B 140B 9,518B 142B 941B 367B 4,633B 376B 368B 16,041B | EV / Sales 2026 * |
7.68x | EV / Sales 2027 * | 6.71x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.03% | ||
| 1 week | -0.43% | ||
| Current month | -0.58% | ||
| 1 month | -1.80% | ||
| 3 months | -5.20% | ||
| 6 months | -1.57% | ||
| Current year | -1.86% |
| 1 week | 433.8 |  | 449.5 |
| 1 month | 420.01 | | 453.45 |
| Current year | 412.27 | | 507.92 |
| 1 year | 362.5 | | 507.92 |
| 3 years | 335.82 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 2019-04-09 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-04 | Sell | Chief Technology Officer | -1,745 | 0.0007% | ||
| 05-31 | Sell | General Counsel | -828 | 0.0003% | ||
| 05-28 | Sell | Chief Technology Officer | -1,974 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | -0.43% | -2.31% | +30.06% | 113B | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| Average | +0.21% | +0.71% | +16.81% | +43.85% | 354.19B | |
| Weighted average by Cap. | -0.22% | +0.99% | +26.81% | +69.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.04B 11.26B 10.38B 9.71B 18.2B 1,239B 18.48B 123B 47.77B 603B 48.93B 47.89B 2,089B | 14.27B 12.32B 11.35B 10.63B 19.92B 1,356B 20.23B 134B 52.27B 660B 53.54B 52.4B 2,285B |
| Net income | 4.45B 3.84B 3.54B 3.32B 6.21B 423B 6.31B 41.83B 16.31B 206B 16.71B 16.35B 713B | 5.05B 4.36B 4.02B 3.76B 7.05B 480B 7.16B 47.49B 18.51B 234B 18.96B 18.56B 809B |
| Net Debt | -12.78B -11.04B -10.18B -9.52B -17.85B -1,215B -18.13B -120B -46.84B -591B -47.98B -46.96B -2,048B | -17.13B -14.8B -13.64B -12.77B -23.92B -1,629B -24.29B -161B -62.78B -793B -64.31B -62.94B -2,745B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 444.92 $ | -0.03% | 924,189 |
| 26-06-11 | 445.04 $ | +2.14% | 1,233,868 |
| 26-06-10 | 435.71 $ | -2.26% | 1,103,240 |
| 26-06-09 | 445.77 $ | +0.63% | 871,497 |
| 26-06-08 | 442.96 $ | -0.87% | 1,149,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
